SG11202103058PA - Preventive and/or therapeutic agent for clostridium difficile infection - Google Patents
Preventive and/or therapeutic agent for clostridium difficile infectionInfo
- Publication number
- SG11202103058PA SG11202103058PA SG11202103058PA SG11202103058PA SG11202103058PA SG 11202103058P A SG11202103058P A SG 11202103058PA SG 11202103058P A SG11202103058P A SG 11202103058PA SG 11202103058P A SG11202103058P A SG 11202103058PA SG 11202103058P A SG11202103058P A SG 11202103058PA
- Authority
- SG
- Singapore
- Prior art keywords
- preventive
- therapeutic agent
- clostridium difficile
- difficile infection
- infection
- Prior art date
Links
- 208000037384 Clostridium Infections Diseases 0.000 title 1
- 206010009657 Clostridium difficile colitis Diseases 0.000 title 1
- 206010054236 Clostridium difficile infection Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000003449 preventive effect Effects 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018191488 | 2018-10-10 | ||
| PCT/JP2019/039254 WO2020075637A1 (en) | 2018-10-10 | 2019-10-04 | Preventive and/or therapeutic agent for clostridium difficile infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202103058PA true SG11202103058PA (en) | 2021-04-29 |
Family
ID=70163989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202103058PA SG11202103058PA (en) | 2018-10-10 | 2019-10-04 | Preventive and/or therapeutic agent for clostridium difficile infection |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11730776B2 (en) |
| EP (1) | EP3865140A4 (en) |
| JP (1) | JP7369709B2 (en) |
| KR (1) | KR20210073531A (en) |
| CN (1) | CN112823014A (en) |
| AU (1) | AU2019358838A1 (en) |
| CA (1) | CA3113221A1 (en) |
| SG (1) | SG11202103058PA (en) |
| WO (1) | WO2020075637A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3574910A4 (en) * | 2017-01-30 | 2020-10-21 | Nutri Co., Ltd. | Mrsa infection protective agent |
| KR20220154089A (en) * | 2020-03-13 | 2022-11-21 | 누트리 컴퍼니 리미티드 | Clostridioides difficile growth inhibitor |
| US20230321163A1 (en) * | 2020-08-21 | 2023-10-12 | Seoul National University R&Db Foundation | Composition For Treating or Preventing Clostridium Difficile Infection |
| WO2023026957A1 (en) * | 2021-08-27 | 2023-03-02 | ニュートリー株式会社 | Agent for prevention and/or treatment of porphyromonas gingivalis infection |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002179580A (en) * | 2000-12-13 | 2002-06-26 | Zenwa Gu | Medicament containing propolis extract, royal jelly, and killed enterococcus faecalis |
| JP2003261453A (en) * | 2002-03-11 | 2003-09-16 | Nippon Berumu Kk | Antitumor agent and radiation-protecting agent consisting of e. faecalis |
| US20050266069A1 (en) * | 2002-09-06 | 2005-12-01 | Simmons Donald L | Stable probiotic microsphere compositions and their methods of preparation |
| JP5308619B2 (en) * | 2006-06-05 | 2013-10-09 | 株式会社アドバンス | healthy food |
| EP2951283A4 (en) * | 2013-02-04 | 2017-01-25 | Seres Therapeutics, Inc. | Compositions and methods |
| WO2016065279A1 (en) * | 2014-10-23 | 2016-04-28 | Symbiotic Health Inc. | A capsule for the oral administration of biopharmaceuticals |
| JP7458706B2 (en) * | 2016-03-24 | 2024-04-01 | パラテック ファーマシューティカルズ，インコーポレイテッド | Methods for treating and preventing Clostridium difficile infections |
| EP3574910A4 (en) * | 2017-01-30 | 2020-10-21 | Nutri Co., Ltd. | Mrsa infection protective agent |
| JP6383458B1 (en) | 2017-05-11 | 2018-08-29 | 西芝電機株式会社 | Rotating electric machine |
| IT201700101704A1 (en) * | 2017-09-12 | 2019-03-12 | Sofar Spa | NEW USE FOR TREATMENT OF DIFFICULT CLOSTRIDIUM INFECTIONS |
-
2019
- 2019-10-04 US US17/279,084 patent/US11730776B2/en active Active
- 2019-10-04 KR KR1020217010608A patent/KR20210073531A/en active Search and Examination
- 2019-10-04 CN CN201980066108.1A patent/CN112823014A/en active Pending
- 2019-10-04 CA CA3113221A patent/CA3113221A1/en active Pending
- 2019-10-04 JP JP2020551101A patent/JP7369709B2/en active Active
- 2019-10-04 WO PCT/JP2019/039254 patent/WO2020075637A1/en unknown
- 2019-10-04 AU AU2019358838A patent/AU2019358838A1/en active Pending
- 2019-10-04 SG SG11202103058PA patent/SG11202103058PA/en unknown
- 2019-10-04 EP EP19870609.5A patent/EP3865140A4/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3865140A8 (en) | 2022-05-18 |
| JP7369709B2 (en) | 2023-10-26 |
| US11730776B2 (en) | 2023-08-22 |
| AU2019358838A1 (en) | 2021-04-15 |
| CA3113221A1 (en) | 2020-04-16 |
| JPWO2020075637A1 (en) | 2021-09-16 |
| EP3865140A1 (en) | 2021-08-18 |
| KR20210073531A (en) | 2021-06-18 |
| EP3865140A4 (en) | 2022-11-09 |
| CN112823014A (en) | 2021-05-18 |
| US20210386797A1 (en) | 2021-12-16 |
| WO2020075637A1 (en) | 2020-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023003461A (en) | Treatment of clostridium difficile infection. | |
| SG11202103058PA (en) | Preventive and/or therapeutic agent for clostridium difficile infection | |
| IL276883A (en) | Compositions, devices, systems, kits and methods for the treatment of a skin condition | |
| IL258854A (en) | Compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer | |
| IL257687B (en) | Hemostatic valve for medical device introducer | |
| SG11201808246SA (en) | Methods for treating and preventing c. difficile infection | |
| HK1249515A1 (en) | Methods and compositions for the prevention and treatment of hearing loss | |
| SG11202003539VA (en) | Compositions and methods for treating liberibacter diseases and other bacterial diseases | |
| SG11202012055PA (en) | Methods and compositions for preventing or treating calciphylaxis | |
| ZA201701671B (en) | Novel pharmaceutical composition for prevention and/or treatment of urinary incontinence | |
| HK1254532A1 (en) | Infection preventive agent for infants | |
| IL284462A (en) | Systems and methods for tissue treatment | |
| HUE045532T2 (en) | Preventive and/or therapeutic agent for immune diseases | |
| PT3810128T (en) | Compositions for treating and/or preventing protein-aggregation diseases | |
| EP3636266A4 (en) | Agent for inhibiting skin trouble and composition for inhibiting skin trouble | |
| EP3581204A4 (en) | Preventive and/or therapeutic agent for infectious diseases or inflammatory diseases | |
| EP3609578A4 (en) | Pharmaceutical combination and its use for treating synucleinopathies | |
| EP3574918A4 (en) | Therapeutic or prophylactic agent and treatment or prevention method for radiation sickness | |
| EP3773582C0 (en) | Selective anti-cancer agent effective for prevention and treatment | |
| EP3146975A4 (en) | Agent for prevention and treatment of chlamydia infection | |
| EP3804722A4 (en) | Treatment agent and pharmaceutical composition for glioma | |
| FI3758799T3 (en) | Composition for the prevention and treatment of skin damages caused by photo-exposure | |
| EP3648654A4 (en) | Synergistic compositions and devices for gynecological procedures | |
| EP3490604C0 (en) | Medicament for the treatment and/or prevention of endometriosis | |
| EP3747407A4 (en) | Protection device for stent and medical device |